Back to Search Start Over

IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein

Authors :
Lopandić, Zorana
Protić-Rosić, Isidora
Todorović, Aleksandra
Glamočlija, Sofija
Gnjatović, Marija Lj.
Ćujic, Danica
Gavrović-Jankulović, Marija
Lopandić, Zorana
Protić-Rosić, Isidora
Todorović, Aleksandra
Glamočlija, Sofija
Gnjatović, Marija Lj.
Ćujic, Danica
Gavrović-Jankulović, Marija
Source :
International Journal of Molecular Sciences
Publication Year :
2021

Abstract

Diagnostic evaluation of specific antibodies against the SARS-CoV-2 virus is mainly based on spike (S) and nucleocapsid (N) proteins. Despite the critical functions in virus infection and contribution to the pattern of immunodominance in COVID-19, exploitation of the most abundant membrane (M) protein in the SARS-CoV-2 serology tests is minimal. This study investigated the recombinant M protein’s immunoreactivity with the sera from COVID-19 convalescents. In silico designed protein was created from the outer N-terminal part (19 aa) and internal C-terminal tail (101–222 aa) of the M protein (YP_009724393.1) and was recombinantly produced and purified. The designed M protein (16,498.74 Da, pI 8.79) revealed both IgM and IgG reactivity with serum samples from COVID-19 convalescents in Western blot. In ELISA, more than 93% (28/30) of COVID-19 sera were positive for IgM detection, and more than 96% (29/30) were positive for specific IgG detection to M protein. Based on the capacity to provoke an immune response and its strong antigenic properties, as shown here, and the fact that it is also involved in the virion entry into host cells, the M protein of the SARS-CoV-2 virus as a good antigen has the potential in diagnostic purposes and vaccine design.

Details

Database :
OAIster
Journal :
International Journal of Molecular Sciences
Notes :
International Journal of Molecular Sciences
Publication Type :
Electronic Resource
Accession number :
edsoai.on1365510359
Document Type :
Electronic Resource